Skip to content

Human Feeding Trial of Iron-Rich Gummy Supplements for the Auxiliary Improvement of Mild to Moderate Iron-Deficiency Anemia

Human Feeding Trial of Iron-Rich Gummy Supplements for the Auxiliary Improvement of Mild to Moderate Iron-Deficiency Anemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125147
Enrollment
Unknown
Registered
2026-05-21
Start date
2026-02-10
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild to moderate iron deficiency anemia

Interventions

Sponsors

Shaanxi Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-45 years, female; 2. Participants with microcytic hypochromic anemia with confirmed iron deficiency etiology and clinical manifestations; 3. Meeting the diagnostic criteria for mild to moderate iron deficiency anemia (hemoglobin 85-110 g/L); 4. With normal liver and kidney function; 5. Volunteers who have provided written informed consent.

Exclusion criteria

Exclusion criteria: 1. Participants with severe diseases of the heart, cerebrovascular, liver, kidney, digestive tract, or psychiatric disorders; 2. Participants with other types of anemia (e.g., thalassemia, megaloblastic anemia) or diseases affecting iron metabolism (e.g., chronic inflammation, tumors); 3. Allergic constitution or allergy to the test sample; 4. Participants with severe anemia; 5. Participants who have taken medications or supplements to improve blood condition (e.g., iron supplements, vitamin C, vitamin B12, folic acid) in the past month, which may affect the results; 6. Pregnant or breastfeeding women; 7. Participants who have participated in other clinical trials in the past 3 months; 8. Participants who did not take the test sample as required or have incomplete data affecting efficacy or safety evaluation; 9. Participants who, in the researcher's opinion, cannot fully comply with the trial arrangements.

Design outcomes

Primary

MeasureTime frame
Hemoglobin;

Secondary

MeasureTime frame
Red blood cell parameters: Mean corpuscular volume (MCV), Mean corpuscular hemoglobin (MCH), Mean corpuscular hemoglobin concentration (MCHC), Red blood cell count (RBC);Iron metabolism indicators: Serum iron (SI), Serum ferritin (SF), Total iron-binding capacity (TIBC), Transferrin saturation (TSAT), Soluble transferrin receptor (sTfR);Hypersensitive C-reactive protein (hs-CRP);Blood glucose level testing;Clinical Symptoms Improvement Scale;Women's Qi and Blood Health Questionnaire;Self-assessment Questionnaire for Hand Rewarming;

Countries

China

Contacts

Public ContactYin Wei

Shaanxi Provincial Hospital of Traditional Chinese Medicine

344124385@qq.com+86 29 8722 5735

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026